NMAKF yields 1078.17% · MRK yields 2.81%● Live data
📍 NMAKF pulled ahead of the other in Year 1
Combined, NMAKF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NMAKF + MRK for your $10,000?
Nemak, S. A. B. de C. V. develops, manufactures, and sells aluminum components for powertrain, e-mobility, and structural applications to the automotive industry in North America, Europe, and internationally. It offers powertrain components, such as cylinder heads, engine blocks, and transmission cases; vehicle structures, including longitudinal members, shock towers, and subframes; and e-mobility components comprising e-motor and battery housings. The company was formerly known as Tenedora Nemak, S. A. de C. V. and changed its name to Nemak, S. A. B. de C. V. in June 2015. Nemak, S. A. B. de C. V. was incorporated in 1979 and is based in Garcia, Mexico. Nemak, S. A. B. de C. V. (BMV:NEMAK A) opearates as a subsidiary of Ford Motor Company.
Full NMAKF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.